Mascoma Wealth Management LLC Amgen Inc Transaction History

Mascoma Wealth Management LLC

$351 Million
Q1 2024

A detailed history of Mascoma Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Mascoma Wealth Management LLC holds 1,833 shares of AMGN stock, worth $572,720. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,833

Previous 2,770 33.83%

Holding current value

$572,720

Previous $797,000 34.63%

% of portfolio

0.15%

Previous 0.24%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$268.87 - $324.56 $251,931 - $304,112	-937 Reduced 33.83%	1,833 $521,000
Q4 2023 Jan 24, 2024	SELL	$255.7 - $288.46 $338,291 - $381,632	-1,323 Reduced 32.32%	2,770 $797,000
Q3 2023 Oct 13, 2023	SELL	$218.65 - $271.46 $36,514 - $45,333	-167 Reduced 3.92%	4,093 $1.1 Million
Q2 2023 Aug 09, 2023	BUY	$214.27 - $253.37 $62,138 - $73,477	290 Added 7.3%	4,260 $945,000
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $7,902 - $9,632	-35 Reduced 0.87%	3,970 $959,000

Q4 2022 Jan 24, 2023	BUY	$229.03 - $291.01 $43,515 - $55,291	190 Added 4.98%	4,005 $0
Q3 2022 Oct 18, 2022	SELL	$224.46 - $253.15 $22,446 - $25,315	-100 Reduced 2.55%	3,815 $860,000
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $8,770 - $9,702	-40 Reduced 1.01%	3,915 $947,000
Q4 2021 Jan 21, 2022	SELL	$198.88 - $227.6 $87,904 - $100,599	-442 Reduced 10.05%	3,955 $889,000
Q3 2021 Oct 06, 2021	SELL	$212.27 - $248.7 $96,582 - $113,158	-455 Reduced 9.38%	4,397 $935,000
Q2 2021 Jul 06, 2021	SELL	$233.58 - $259.14 $34,803 - $38,611	-149 Reduced 2.98%	4,852 $1.18 Million
Q1 2021 Apr 26, 2021	BUY	$221.91 - $258.6 $158,887 - $185,157	716 Added 16.71%	5,001 $1.24 Million
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $74,867 - $89,153	346 Added 8.78%	4,285 $985,000
Q3 2019 Nov 21, 2019	BUY	$174.11 - $208.62 $43,527 - $52,155	250 Added 6.78%	3,939 $762,000
Q2 2019 Jul 29, 2019	BUY	$166.7 - $195.41 $41,675 - $48,852	250 Added 7.27%	3,689 $680,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $76,869 - $86,649	425 Added 14.1%	3,439 $653,000
Q4 2018 Jan 28, 2019	BUY	$178.4 - $208.25 $55,482 - $64,765	311 Added 11.51%	3,014 $587,000
Q3 2018 Nov 08, 2018	SELL	$185.29 - $208.89 $233,094 - $262,783	-1,258 Reduced 31.76%	2,703 $560,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $16,771 - $18,837	101 Added 2.62%	3,961 $731,000
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $13,723 - $16,038	81 Added 2.14%	3,860 $658,000
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $160,350 - $179,160	950 Added 33.58%	3,779 $707,000
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $473,263 - $540,339	2,829	2,829 $527,000

Others Institutions Holding AMGN

# of Institutions

2,930

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mascoma Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mascoma Wealth Management LLC with notifications on news.

Account

Mascoma Wealth Management LLC Amgen Inc Transaction History